Fenny Aztari, M F Arrozi, Ratna Indrawati


Thypoid fever was first rank of the top 10 disease hospitalizations at An-nisa Hospital. Still founded differences between hospital’s price and INA-CBGs price, which can be impact to hospital’s finance. The purpose of this study is to analyse determinant between hospital’s price and INA-CBGs price and analyse influence factor of hospital’s price. The study focus was hospitalize of thypoid fever without complication at An-nisa Hospital. Research design is corelational-comparatif study. The number of sample was 320 medical record. Normality test was analyse with kolmogorov-smirnov test, correlational was analyse with spearman test and comparative test with wilcoxon test. The result showed that founded differences between hospital’s price and INA-CBGs price, specially at medical fee, drugs cost, and others cost. The significant differences caused by difference way to count price, Hospital’s price was based on unit cost. Meanwhile, INA-CBGs price was count by mean hospital’s price from certain hospital. The result also founded correlation between accomodation, others cost, medical fee, drugs cost and supporting examination with hospital’s price. The implication of this study is need more control of clinical pathway implementation, periodic audit of clinical pathway implementation and maximised function of case manager to cost control dan quality control of healthcare service.


Keyword : Determinant factors, Hospital’s price, INA-CBGs price, demam tifoid

Teks Lengkap:



Aljunid. (2013). Sistem Casemix Untuk Pemula, Konsep dan Aplikasi Untuk Negara Berkembang (Penerapan di Indonesia). Jakarta: Energy Painting.

Armen, F., & Azwar, V. (2013). Dasar-Dasar Manajemen Keuangan Rumah Sakit. Jakarta: Gosyen Publishing.

de Kraker, M. E. A., Stewardson, A. J., & Harbarth, S. (2016). Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? PLoS Medicine, 13(11), 1–6.

Departemen Kesehatan RI. (2007). Riset kesehatan dasar. depkes RI.

Hansen, D. R., & Mowen, M. M. (2009). Managerial Accounting. Jakarta: Salemba Empat.

Kinsman, L., Rotter, T., James, E., Snow, P., & Willis, J. (2010). What is a clinical pathway? Development of a definition to inform the debate. BMC Medicine, 8, 8–10.

Nelwan, R. (2012). Tata Laksana Terkini Demam Tifoid. IDI - Continuing Madical Education, 39(4), 247–250. Retrieved from Tata Laksana Terkini Demam Tifoid.pdf

Peraturan Menteri Kesehatan RI No 76. (2016). Permenkes RI No 76 Tahun 2016 Tentang Pedoman Indonesia Case Base Group (INA-CBG), 1–257.

Peraturan Menteri Kesehatan RI No 85. (2015). Permenkes RI No. 85 Tentang Pola Tarif Nasional Rumah Sakit. Departemen Kesehatan RI, 1.

Purba, I. E., Wandra, T., Nugrahini, N., Nawawi, S., & Kandun, N. (2016). Program Pengendalian Demam Tifoid di Indonesia: Tantangan dan Peluang. Media Penelitian Dan Pengembangan Kesehatan, 26(2).

Rotter, T., Kinsman, L., El, J., Machotta, A., Gothe, H., Willis, J., … Kugler, J. (2010). Clinical pathways : effects on professional practice , patient outcomes , length of stay and hospital costs ( Review ). Cochrane Database of Systematic Reviews, (3).


  • Saat ini tidak ada refbacks.